California State Teachers Retirement System Has $67.54 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

California State Teachers Retirement System cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 6.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 113,648 shares of the biotechnology company's stock after selling 7,997 shares during the period. California State Teachers Retirement System owned approximately 0.15% of Axon Enterprise worth $67,543,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC grew its position in Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after purchasing an additional 65,097 shares in the last quarter. Capital World Investors grew its position in Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after purchasing an additional 841,772 shares in the last quarter. Alliancebernstein L.P. increased its stake in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after buying an additional 812,337 shares during the last quarter. Finally, Norges Bank bought a new stake in Axon Enterprise during the 4th quarter worth about $482,081,000. Institutional investors own 79.08% of the company's stock.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of Axon Enterprise stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $738.84, for a total transaction of $960,492.00. Following the completion of the sale, the director now directly owns 4,829 shares of the company's stock, valued at approximately $3,567,858.36. This trade represents a 21.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,969 shares of company stock worth $23,127,314. Insiders own 4.40% of the company's stock.

Wall Street Analyst Weigh In

AXON has been the subject of several analyst reports. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Needham & Company LLC increased their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Barclays boosted their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. The Goldman Sachs Group upped their price objective on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Finally, Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $652.73.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded up $7.62 during midday trading on Friday, hitting $731.37. 422,330 shares of the company's stock were exchanged, compared to its average volume of 743,966. The company's 50 day moving average price is $603.25 and its 200 day moving average price is $603.88. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $748.80. The firm has a market capitalization of $56.94 billion, a PE ratio of 188.98, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company's quarterly revenue was up 31.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.15 earnings per share. As a group, analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.